Insider Transactions Reported by 18 Insiders of Skye Bioscience, Inc.

Symbol
SKYE on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Skye Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andrew J. Schwab Director $34,663,397 -$800,549 -2.3% 06 Feb 2026
5AM Partners VII, LLC 10%+ Owner $34,663,397 -$800,549 -2.3% 21 Aug 2025
Versant Ventures III, LLC 10%+ Owner $9,386,012 18 Aug 2023
Emerald Health Sciences Inc. 10%+ Owner $3,167,928 10 Nov 2022
Kaitlyn Arsenault Chief Financial Officer $835,935 06 Feb 2026
Christopher Twitty Chief Scientific Officer $147,251 06 Feb 2026
James L. Heppell Director 14 Sep 2021
Deborah H. Charych Director 06 Feb 2026
Margaret Dalesandro Director 29 Feb 2024
Praveen Tyle Director 29 Feb 2024
Paul A. Grayson Director 06 Feb 2026
Keith Wayne Ward Director 29 Feb 2024
Punit Dhillon Chief Executive Officer, Director 06 Feb 2026
Tuan Tu Diep Chief Development Officer 06 Feb 2026
Sukhwinder Singh Rai Director 05 Jan 2023
Annalisa Jenkins Director 06 Feb 2026
Karen L. Smith Director 06 Feb 2026
Puneet S. Arora Chief Medical Officer 06 Feb 2026

Recent Insider Transactions by Companies or Individuals for Skye Bioscience, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Andrew J. Schwab SKYE Stock Option (Right to Buy) Award 35,000 35,000 06 Feb 2026 Direct
Paul A. Grayson SKYE Stock Option (Right to Buy) Award 35,000 35,000 06 Feb 2026 Direct
Karen L. Smith SKYE Stock Option (Right to Buy) Award 35,000 35,000 06 Feb 2026 Direct
Kaitlyn Arsenault SKYE Stock Option (Right to Buy) Award 125,000 125,000 06 Feb 2026 Direct
Christopher Twitty SKYE Stock Option (Right to Buy) Award 150,000 150,000 06 Feb 2026 Direct
Deborah H. Charych SKYE Stock Option (Right to Buy) Award 35,000 35,000 06 Feb 2026 Direct
Annalisa Jenkins SKYE Stock Option (Right to Buy) Award 35,000 35,000 06 Feb 2026 Direct
Tuan Tu Diep SKYE Stock Option (Right to Buy) Award 125,000 125,000 06 Feb 2026 Direct
Puneet S. Arora SKYE Stock Option (Right to Buy) Award 125,000 125,000 06 Feb 2026 Direct
Punit Dhillon SKYE Stock Option (Right to Buy) Award 280,000 280,000 06 Feb 2026 Direct
Andrew J. Schwab SKYE Common Stock Sale -10.1% $22,127 $3.42 -6,470 57,493 22 Aug 2025 By 5AM Co-Investors II, L.P.
Andrew J. Schwab SKYE Common Stock Sale -10.1% $560,808 $3.42 -163,979 1,457,064 22 Aug 2025 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -10.1% $22,127 $3.42 -6,470 57,493 22 Aug 2025 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -10.1% $560,808 $3.42 -163,979 1,457,064 22 Aug 2025 By 5AM Ventures II, L.P.
Andrew J. Schwab SKYE Common Stock Sale -3.49% $8,261 $3.57 -2,314 63,963 21 Aug 2025 By 5AM Co-Investors II, L.P.
Andrew J. Schwab SKYE Common Stock Sale -3.49% $209,352 $3.57 -58,642 1,621,043 21 Aug 2025 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -3.49% $8,261 $3.57 -2,314 63,963 21 Aug 2025 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -3.49% $209,352 $3.57 -58,642 1,621,043 21 Aug 2025 By 5AM Ventures II, L.P.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.